March 2019 //
New article in Forbes from the Start-Up Nation discusses “How Israel Turned Decades Of Medical Data Into Digital Health Gold”.
Read more to learn how Taliaz uses genetic information and other data to enable immediate adjustments of antidepressant doses for patients.
Digitization of medical records and new medical technologies have yet to impact large parts of the world’s medical institutions. This makes for inefficiency.
Benjamin Netanyahu announced a $300 million initiative for utilizing big data in 2018. By doing so, researchers, entrepreneurs, and medical institutions could access large amounts of anonymized data about patients from electronic health records.
Additionally, the digitization project will enable patients to receive personalized medical treatment. By using smart, computerized systems, the treating physician can apply the knowledge learnt from treating a large number of patients as a tool for decision-making and individualized treatment, based on the patient’s individual needs.
For example, a solution developed by Taliaz, an Israeli medtech firm exhibiting at this week’s MEDinISRAEL conference, uses genetic information and other data to enable immediate adjustments of antidepressant doses for patients, with what it says is a 70%-80% accuracy rate. The usual accuracy rate for existing methods of doing this is about 30%-40%, and that is usually only after long months of experimentation with different drugs until the appropriate one for the patient is found.